Cargando…
Identification of TP53 mutation associated-immunotype and prediction of survival in patients with hepatocellular carcinoma
BACKGROUND: Stratification of tumors is necessary to achieve better clinical outcomes. Hepatocellular carcinoma (HCC) is commonly associated with mutation of the TP53 gene and heterogeneity in immune cell content. However, TP53 mutation-associated immunotype of HCC has not been reported yet. This st...
Autores principales: | Shi, Muqi, Wang, Yan, Tang, Weidong, Cui, Xiaohong, Wu, Han, Tang, Yijie, Wang, Peng, Wu, Wei, Zhang, Haijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186599/ https://www.ncbi.nlm.nih.gov/pubmed/32355765 http://dx.doi.org/10.21037/atm.2020.02.98 |
Ejemplares similares
-
Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma
por: Li, Wei, et al.
Publicado: (2019) -
Advances in immunotyping of colorectal cancer
por: Wu, Yinhang, et al.
Publicado: (2023) -
Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer
por: Zhou, Jie, et al.
Publicado: (2022) -
Identification of TP53 mutation-associated prognostic genes and investigation of the immune cell infiltration in patients with hepatocellular carcinoma
por: Yang, Qijun, et al.
Publicado: (2023) -
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
por: Wang, Longrong, et al.
Publicado: (2021)